Leo Pharma picks Christophe Bourdon as CEO after one-year stint at failed Danish meme stock Orphazyme

Christophe Bourdon's time at Danish meme stock Orphazyme, which has a rejected rare disease drug, will come to a head in March. He will assume the helm at Leo Pharma as it prepares to launch its eczema drug.